Table 2.
Surrogate markers | ICAS-related | Embolic | |
---|---|---|---|
Before starting EVT | Atrial fibrillation, 2017 (13) | +* | +++ |
Susceptibility artifact on MR gradient echo image, 2015 (28) | + | +++ | |
Hyperdense artery sign on NECT, 2017 (29) | + | ++ | |
Truncal-type occlusion on CT angiography, 2017 (13), 2016 (14) | +++ | + | |
During the EVT | Truncal-type occlusion, 2016 (7), 2017 (13), 2016 (14) | ++++ | + |
Residual stenosis, 2014 (8), 2015 (16), 2018 (23) | ++++ | + |
EVT, endovascular treatment; ICAS, intracranial atherosclerotic stenosis; MR, magnetic resonance; NECT, non-enhanced computed tomography; CT, computed tomography.
The number of + sign indicates to have more probability to have ICAS-related or embolic surrogate markers.